|
Emergent BioSolutions Inc.
April 8, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Emergent BioSolutions Inc. (“Emergent BioSolutions” or the “Company”) (NYSE: EBS).
|
|
Credit Suisse AG
April 1, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Credit Suisse Group AG (“Credit Suisse” or the “Company”), including purchasers of Credit Suisse American Depositary Shares (“ADSs”) (NYSE: CS).
|
|
Romeo Power, Inc.
April 5, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Romeo Power, Inc. (“Romeo Power” or the “Company”) (NYSE: RMO).
|
|
Danimer Scientific Inc.
March 22, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Danimer Scientific Inc. (“Danimer” or the “Company”) (NYSE: DNMR).
|
|
Plug Power Inc.
March 22, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Plug Power Inc. (“Plug Power” or the “Company”) (NASDAQ: PLUG). Plug Power claims to be a leading provider of clean hydrogen and zero-emission fuel cell solutions. A complaint has been filed on behalf of investors who purchased or otherwise acquired Plug Power securities between November 9, 2020 and March 1, 2021 (the “Class Period”).
|
|
FuboTV Inc.
March 16, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of FuboTV Inc. (“Fubo” or the “Company”) (NYSE: FUBO). A complaint has been filed on behalf of investors who purchased or otherwise acquired Fubo common shares between March 23, 2020 and January 4, 2021 (the “Class Period”).
|
|
Lordstown Motors Corp.
March 12, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Lordstown Motors Corp. (“Lordstown” or the “Company”) (NASDAQ: RIDE).
|
|
Jianpu Technology Inc.
March 8, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Jianpu Technology Inc. (“Jianpu” or the “Company”) (NYSE: JT). A complaint has been filed on behalf of investors who purchased Jianpu American Depositary Shares (“ADSs”) between May 29, 2018 and February 16, 2021 (the “Class Period”).
|
|
XL Fleet Corp.
March 4, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of XL Fleet Corp. (“XL” or the “Company”) (NYSE: XL).
|
|
Ifinity Capital
February 25, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Infinity Q Diversified Alpha Fund Institutional Class (NASDAQ: IQDNX) and Infinity Q Diversified Alpha Fund Investor Class (NASDAQ: IQDAX) following Infinity Q Capital Management LLC’s request to the Securities and Exchange Commission (“SEC”) to halt redemptions.
|
|
Workhorse Group, Inc.
February 24, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Workhorse Group, Inc. (“Workhorse” or the “Company”) (NASDAQ: WKHS).
|
|
Ebix, Inc.
February 22, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Ebix, Inc. (“Ebix” or the “Company”) (NASDAQ: EBIX).
|
|
CleanSpark, Inc.
February 19, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of CleanSpark, Inc. (“CleanSpark” or the “Company”) (NASDAQ: CLSK). A complaint has been filed on behalf of investors who purchased CleanSpark securities between December 31, 2020 and January 14, 2021 (the “Class Period”).
|
|
Clover Health Investments Corp.
February 5, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Clover Health Investments Corp. (“Clover” or the “Company”) (NASDAQ: CLOV).
|
|
Tricida, Inc.
January 29, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Tricida, Inc. (“Tricida” or the “Company”) (NASDAQ: TCDA). A complaint has been filed on behalf of investors who purchased Tricida securities between September 4, 2019 and October 28, 2020 (the “Class Period”).
|
|
AstraZeneca PLC
January 29, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors who purchased AstraZeneca PLC’s American Depositary Shares (“ADSs”) (NASDAQ: AZN) between May 21, 2020 and November 20, 2020 (the “Class Period”).
|
|
GTT Communications, Inc.
January 21, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of GTT Communications, Inc. (“GTT” or the “Company”) (NYSE: GTT). A complaint has been filed on behalf of investors who purchased GTT’s publicly traded securities between May 5, 2016 and November 9, 2020 (the “Class Period”).
|
|
Triterras, Inc.
January 14, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Triterras, Inc. (“Triterras” or the “Company”) (NASDAQ: TRIT; TRITW). A complaint has been filed on behalf of investors who purchased Triterras securities between August 20, 2020 and December 16, 2020, inclusive (the “Class Period”)
|
|
Magnite, Inc.
January 7, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims against Magnite, Inc. (“Magnite” or the “Company”) (Nasdaq: MGNI) for violations of the federal securities laws.
|
|
QuantumScape Corporation
January 7, 2021 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of QuantumScape Corporation (“QuantumScape” or the “Company”) (NYSE: QS). A complaint has been filed on behalf of investors who purchased QuantumScape securities between November 27, 2020 and December 31, 2020, inclusive (the “Class Period”).
|
|
Alibaba Group
December 24, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Alibaba Group Holding Limited (“Alibaba” or the “Company”) (NYSE: BABA).
|
|
CD Projekt SA
December 21, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors who purchased the American Depositary Receipts (“ADRs”) of CD Projekt SA (“CD Projekt” or the “Company”) (OTC: OTGLY).
|
|
Penumbra, Inc.
December 17, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Penumbra, Inc (“Penumbra” or the “Company”) (NYSE: PEN).
|
|
FireEye, Inc.
December 16, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of FireEye, Inc. (“FireEye” or the “Company”) (NASDAQ: FEYE).
|
|
SolarWinds Corporation
December 16, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of SolarWinds Corporation (“SolarWinds” or the “Company”) (NYSE: SWI), a software company that provides IT management tools.
|
|
Covia Holdings Corporation
December 11, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Covia Holdings Corporation (“Covia” or the “Company”) (OTC: CVIAQ). A complaint has been filed on behalf of investors who purchased the Company’s securities between March 15, 2016 and June 29, 2020, inclusive (the “Class Period”).
|
|
Splunk, Inc.
December 3, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Splunk Inc. (“Splunk” or the “Company”).
|
|
Boston Scientific Corporation
November 18, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims against Boston Scientific Corporation (“BSX” or the “Company”) for violations of the federal securities laws.
|
|
Raytheon Technologies Corporation
October 28, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors who purchased shares of Raytheon Technologies Corporation (“Raytheon” or the “Company”) (NYSE: RTX). Raytheon is an aircraft manufacturing company.
|
|
Eli Lilly and Company
October 22, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors who purchased shares of Eli Lilly and Company (“Eli Lilly” or the “Company”) (NYSE: LLY).
|
